ZINZINO AB (PUBL.): PRELIMINARY SALES REPORT FEBRUARY 2026

Report this content

Zinzino group revenue increased with a total of 32 %, compared with the previous year.

 

The revenue in February for Zinzino's sales markets increased by 32 % and amounted to SEK 281.1 (212.7) million. Faun Pharma's external sales increased and amounted to SEK 5.2 (4.2) million. Overall, the Group increased revenues by 32 % to SEK 286.3 (216.9) million compared with the previous year.

Accumulated revenue for January – February 2026 increased by 26 % to SEK 568.6 (450.8) million.

 

Revenues were distributed as follows:

 

Regions,MSEK 26-Feb 25-Feb Change YTD 2026 YTD 2025 Change
The Nordics 22.5 24.8 -9% 50.1 50.5 -1%
Central Europe 81.8 57.4 43% 171.0 126.8 35%
East Europe 26.2 29.0 -10% 55.9 63.2 -12%
South & West Europe 50.2 37.8 33% 97.2 82.0 19%
The Baltics 8.5 8.8 -3% 18.9 19.3 -2%
North America 67.5 32.5 108% 109.9 53.8 104%
South America 3.6 1.2 200% 7.5 2.1 257%
Asia-Pacific 18.6 19.7 -6% 41.7 41.2 1%
Africa 2.2 1.5 47% 4.1 3.0 37%
Zinzino 281.1 212.7 32% 556.3 441.9 26%
Faun Pharma 5.2 4.2 24% 12.3 8.9 38%
Zinzino Group 286.3 216.9 32% 568.6 450.8 26%

Countries in regions:

-The Nordics: Denmark, Faroe Island, Finland, Iceland, Norway, Sweden

-Central Europe: Austria, Germany, Switzerland

-East Europe: Czech Republic, Slovakia, Hungary, Poland, Romania

-South & West Europe: Cyprus, France, Greece, Italy, Luxembourg, Malta, Netherlands, Slovenia, Spain, United Kingdom, Belgium, Ireland, Serbia, Turkey, Canary Islands

-The Baltics: Estonia, Latvia, Lithuania

-North America: Canada, USA, Mexico

-South America: Peru, Colombia

-Asia-Pacific: Australia, New Zealand, Hong Kong, India, Malaysia, Singapore, Taiwan, Thailand, China, Philippines, South Korea

-Africa: South Africa

 

For more information:

Dag Bergheim Pettersen CEO Zinzino +47 (0) 932 25 700, dag@zinzino.com

Fredrik Nielsen CFO Zinzino +46 (0) 707 900 174, fredrik.nielsen@zinzino.com

 

Pictures for publication free of charge: marketing@zinzino.com

 

Certified Adviser: Tapper Partners AB

Zinzino is a global health tech company from Scandinavia, pioneering a new standard in personal health through advanced home health tests and scientifically proven nutritional supplements. Listed on the Nasdaq First North Premier Growth Market, the company’s test-based, personalized nutrition strategy empowers individuals to take charge of their long-term health with science-based insights and targeted solutions. Its third-party validated products are available through direct sales distributors in more than 100 markets worldwide. Zinzino’s headquarters are located in Gothenburg, Sweden, with additional offices across Europe, Asia, and Australia.

Subscribe